SCHEMBL342124

SCHEMBL342124

CSC(C)C(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2451003 1.00
SCHEMBL16181947 0.85 SLC7A5 (0.50)
SCHEMBL6684752 0.81 SLC7A5 (0.57)
SCHEMBL2313042 0.79 SLC7A5 (0.55)
SCHEMBL16300972 0.77
SCHEMBL16490238 0.77
Valine SCHEMBL9321177 0.76 SLC7A5 (0.83)
Valine SCHEMBL628974 0.75 SLC7A5 (0.94)
Valine SCHEMBL135483 0.75
Valine SCHEMBL4078935 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023097407-A1 MODIFIED AMATOXINS AND USES THEREOF THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2023-06-08 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-9603943-B2 Polyesteramide platform for site specific drug delivery ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2017-03-28 US disclosed
US-9603943-B2 Polyesteramide platform for site specific drug delivery ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2017-03-28 US disclosed
US-20150290336-A1 POLYESTERAMIDE PLATFORM FOR SITE SPECIFIC DRUG DELIVERY ABBOTT CARDIOVASCULAR SYSTEMS (US) 2015-10-15 US disclosed
US-9095619-B2 Polyesteramide platform for site specific drug delivery ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2015-08-04 US disclosed
EP-2450194-B1 Recording medium CANON KK (JP) 2015-06-17 EP disclosed
US-20150010491-A1 POLYESTERAMIDE PLATFORM FOR SITE SPECIFIC DRUG DELIVERY ABBOTT CARDIOVASCULAR SYSTEMS (US) 2015-01-08 US disclosed
US-8865148-B2 Polyesteramide platform for site specific drug delivery ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) 2014-10-21 US disclosed
US-8722159-B2 Recording medium CANON KABUSHIKI KAISHA (JP) 2014-05-13 US disclosed
US-8658210-B2 Polyesteramide platform for site specific drug delivery ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) 2014-02-25 US disclosed
CN-102336083-B Recording medium CANON KK 2014-01-22 CN disclosed
EP-2450194-A2 Recording medium Canon Kabushiki Kaisha (JP) 2012-05-09 EP disclosed
US-20120015119-A1 RECORDING MEDIUM CANON KABUSHIKI KAISHA (JP) 2012-01-19 US disclosed
US-20070243256-A1 Polyesteramide platform for site specific drug delivery ABBOTT CARDIOVASCULAR SYSTEMS INC. 2007-10-18 US disclosed
EP-0595163-B1 Process for producing L-isoleucine KYOWA HAKKO KOGYO KK (JP) 1998-06-24 EP disclosed
EP-0131171-B1 CORYNEFORM BACTERIA CARRYING RECOMBINANT PLASMIDS AND THEIR USE IN THE FERMENTATIVE PRODUCTION OF L-THREONINE AND L-ISOLEUCINE AJINOMOTO CO., INC. (JP) 1987-10-21 EP disclosed
US-4601983-A Coryneform bacteria carrying recombinant plasmids and their use in the fermentative production of L-threonine and L-isoleucine AJINOMOTO CO., INC. (JP) 1986-07-22 US disclosed
EP-0131171-A1 Coryneform bacteria carrying recombinant plasmids and their use in the fermentative production of l-threonine and l-isoleucine AJINOMOTO CO., INC. (JP) 1985-01-16 EP disclosed
US-3959075-A CULTURING CORYNEFORM MUTANT KYOWA HAKKO KOGYO CO., LTD. (JA) 1976-05-25 US disclosed